In re Vaxart, Inc. Securities Litigation
Case Number:
3:20-cv-05949
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Akin Gump
- Baker Botts
- Berman Tabacco
- Bleichmar Fonti
- Boies Schiller
- Conrad Metlitzky
- Goodwin Procter
- Hagens Berman
- Hanson Bridgett
- Paul Hastings
- Robbins LLP
- Scott&Scott
- Thompson Hine
- Umhofer Mitchell
- Williams & Connolly
- Willkie Farr
- Wilson Elser
Companies
Sectors & Industries:
-
August 24, 2020
Biotech Co. Lied About COVID-19 Vaccine, Investors Say
Investors in Vaxart Inc. accused the San Francisco-headquartered biotechnology company of lying about its COVID-19 vaccine candidate in order to inflate its stock price, according to a complaint filed Monday in California federal court.
- ← Previous
- 1
- 2
- Next →